{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:09:32Z","timestamp":1781042972171,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00789"],"award-info":[{"award-number":["PI20\/00789"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","revespcardiol.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.rec.2024.02.021","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T22:13:59Z","timestamp":1714601639000},"page":"851-858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial"],"prefix":"10.1016","volume":"77","author":[{"given":"Francisco J.","family":"Pastor-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris P.","family":"Garrido-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Pe\u00f1afiel-Verd\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Fern\u00e1ndez-Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Manzano-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Oliva-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Caro-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Hern\u00e1ndez-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo A.","family":"Pascual-Figal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2024.02.021_bib0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2024.02.021_bib0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.recesp.2022.07.002","article-title":"Effects of guideline-directed medical therapy in patients with left bundle branch block-induced cardiomyopathy","volume":"76","author":"Garc\u00eda-Rodeja Arias","year":"2023","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2024.02.021_bib0120","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.02.021_bib0125","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2012.01.065","article-title":"Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study","volume":"59","author":"Hsu","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.02.021_bib0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijcard.2019.06.008","article-title":"Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity","volume":"299","author":"Sanna","year":"2020","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.021_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2024.02.021_bib0140","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jacc.2020.01.040","article-title":"Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy","volume":"75","author":"Nijst","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.02.021_bib0145","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.02.021_bib0150","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jacc.2010.05.055","article-title":"REVERSE Study Group. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study","volume":"56","author":"Linde","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.02.021_bib0155","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/eurheartj\/ehn577","article-title":"The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial","volume":"30","author":"Wikstrom","year":"2009","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.02.021_bib0160","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/CIRCULATIONAHA.105.538272","article-title":"Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy","volume":"112","author":"Yu","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2024.02.021_bib0165","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.amjcard.2009.12.058","article-title":"Identification and characterization of super-responders after cardiac resynchronization therapy","volume":"105","author":"Reant","year":"2010","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2024.02.021_bib0170","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.hrthm.2010.04.005","article-title":"Characterization of super-response to cardiac resynchronization therapy","volume":"7","author":"Rickard","year":"2010","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.rec.2024.02.021_bib0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jacc.2008.10.032","article-title":"Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up","volume":"53","author":"Ypenburg","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.02.021_bib0180","first-page":"1668","article-title":"Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: \u201creal world\u201d experience from a single tertiary care centre","volume":"97","author":"Steffel","year":"2011","journal-title":"Heart Br Card Soc."},{"key":"10.1016\/j.rec.2024.02.021_bib0185","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.114.011283","volume":"130","author":"Ruwald","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2024.02.021_bib0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cardfail.2015.10.015","article-title":"Normalization of Left Ventricular Ejection Fraction and Incidence of Appropriate Antitachycardia Therapy in Patients with Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Death","volume":"22","author":"House","year":"2016","journal-title":"J Card Fail."},{"key":"10.1016\/j.rec.2024.02.021_bib0195","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/ejhf.152","volume":"16","author":"van der Heijden","year":"2014","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2024.02.021_bib0200","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/eurheartj\/eht514","article-title":"Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy","volume":"35","author":"Schmidt","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.02.021_bib0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cardfail.2017.03.001","article-title":"Feasibility and Association of Neurohumoral Blocker Up-titration After Cardiac Resynchronization Therapy","volume":"23","author":"Martens","year":"2017","journal-title":"J Card Fail."},{"key":"10.1016\/j.rec.2024.02.021_bib0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2017.03.051","article-title":"Pharmacological treatment changes of chronic heart failure during cardiac resynchronization therapy: A 1-year follow-up study","volume":"238","author":"Rinkuniene","year":"2017","journal-title":"Int J Cardiol."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724001439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724001439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T11:53:30Z","timestamp":1727351610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585724001439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1885585724001439"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2024.02.021","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2024.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2024.02.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}